Medincell Sa · EURONEXT:MEDCL
Medincell Sa — H1 2021 Earnings Presentation
9 slides from Medincell Sa's earnings presentation, December 2021
Slide 1: 2021 Half-Year financial results
Videoconference 2021 Half-Year financial results April-September, 2021
Slide 2: Product pipeline
mdc-GRT mdc-ANG Tacrolimus Confidential Transplantation Antipsychotic mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectin Confidential (non-MPA) Malaria Antipsychotic Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidential Ivermectine Celecoxib Risperidone Pain Covid-19 Pain & inflammation Schizophren
Slide 3: Product pipeline
mdc-GRT mdc-ANG Tacrolimus Confidential Transplantation Antipsychotic mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectin Confidential (non-MPA) Malaria Antipsychotic Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidential Ivermectine Celecoxib Risperidone Pain Covid-19 Pain & inflammation Schizophren
Slide 4: Product pipeline
mdc-GRT mdc-ANG Tacrolimus Confidential Transplantation Antipsychotic mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectin Confidential (non-MPA) Malaria Antipsychotic Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidential Ivermectine Celecoxib Risperidone Pain Covid-19 Pain & inflammation Schizophren
Slide 5: Product pipeline
mdc-GRT mdc-ANG Tacrolimus Confidential Transplantation Antipsychotic mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectin Confidential (non-MPA) Malaria Antipsychotic Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidential Ivermectine Celecoxib Risperidone Pain Covid-19 Pain & inflammation Schizophren
Slide 6: Product pipeline
mdc-GRT mdc-ANG Tacrolimus Confidential Transplantation Antipsychotic mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectin Confidential (non-MPA) Malaria Antipsychotic Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidential Ivermectine Celecoxib Risperidone Pain Covid-19 Pain & inflammation Schizophren
Slide 7: Pipeline (French version)
mdc-GRT mdc-ANG Tacrolimus Confidentiel Transplantation Antipsychotique mdc-STM mdc-WWM mdc-TJK Progestatif Ivermectine Confidentiel (non-MPA) Malaria Antipsychotique Contraception mdc-KPT mdc-TTG mdc-CWM mdc-IRM Confidentiel Ivermectine Celecoxib Risperidone Douleur Covid-19 Douleur & inflammation
Slide 8: Finance results – First semester (April-Sept 2021)
Finance results– First semester (April-Sept 2021) Revenue: 4,1 M€ Operating expenses: 15,3 M€ Cash consumption from operations: 11,3 M€ Available Cash as of September 30, 2021 34,4 M€ in cash 3,0 M€ in non risky financial assets •
Slide 9: Thank you
Thank you MedinCell 3, rue des frères Lumière 34830 Jacou • France www.medincell.com